Go Pro
OTCMKTS:PBIO

Pressure BioSciences (PBIO) Stock Price, News & Analysis

Pressure BioSciences logo
$0.0004 0.00 (0.00%)
As of 08/28/2026

About Pressure BioSciences Stock (OTCMKTS:PBIO)

Advanced

Key Stats

Today's Range
$0.0004
$0.0004
50-Day Range
N/A
52-Week Range
$0.00
$0.20
Volume
N/A
Average Volume
10,998 shs
Market Capitalization
$17.19 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pressure BioSciences, Inc., headquartered in South Easton, Massachusetts, develops and markets novel pressure-based instruments and consumables for sample preparation in the life sciences, biotechnology and pharmaceutical industries. The company’s core innovation, Pressure Cycling Technology (PCT), uses alternating cycles of high hydrostatic pressure to facilitate efficient and reproducible cell disruption, protein extraction and subcellular fractionation. Its flagship Barocycler® instrument has been adopted by researchers working in proteomics, biomarker discovery, vaccine development and pathogen inactivation workflows.

In addition to its instrument platform, Pressure BioSciences offers a range of proprietary consumables—including pressure-resistant processing tubes and optimized reagent kits—designed to support diverse sample types such as tissue, microbes and blood derivatives. The company also markets an Ultra Shear Technology (UST) system for high-pressure homogenization, targeting applications in food science, nutraceutical development and personal care product formulation.

Pressure BioSciences serves a global customer base through direct sales and distribution partners in North America, Europe and Asia. Its clients include academic and government research institutions, contract research organizations and biotechnology and pharmaceutical companies. Although it operates as a small-cap public company on the OTC markets, the firm has established collaborative relationships with leading research centers and regularly showcases its sample-preparation solutions at scientific conferences and trade exhibitions.

AI Generated. May Contain Errors.

Receive PBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PBIO Stock News Headlines

Pressure BioSciences Inc.
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
The big blood pressure experiment
See More Headlines

PBIO Stock Analysis - Frequently Asked Questions

Pressure BioSciences' stock was trading at $0.0005 at the start of the year. Since then, PBIO stock has decreased by 20.0% and is now trading at $0.0004.

Pressure BioSciences Inc. (OTCMKTS:PBIO) announced its quarterly earnings data on Friday, February, 7th. The company reported ($0.15) earnings per share (EPS) for the quarter.

Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pressure BioSciences investors own include Hydrofarm Holdings Group (HYFM), Advanced Micro Devices (AMD), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP) and Novavax (NVAX).

Company Calendar

Last Earnings
2/07/2025
Today
8/31/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:PBIO
CIK
830656
Employees
10
Year Founded
2004

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.98 million
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
42,970,000
Free Float
38,327,000
Market Cap
$17.19 thousand
Optionable
Not Optionable
Beta
5.80

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:PBIO) was last updated on 9/1/2026 by MarketBeat.com Staff.
From Our Partners